Opharmic Technology is a medtech company with a vision and mission to develop technologies that improve patients well-being by partnering with pharmaceutical companies with technically and clinically meaningful products. Leveraging on our proprietary ultrasound technology, Opharmic offers novel and versatile solutions in drug delivery and therapy in ophthalmology and beyond.
Launched in 2021, Opharmic's first platform technology for non-invasive ocular induction - MeticTouch, has attracted pharma partners of various sizes from around the world to test and adopt the novel technology to their new and/or existing products at all stages of drug discovery.
Patent protected in over 13 territories covering 30 countries, the needle-less MeticTouch technology enables API of various size and characteristics to reach target sites effectively and efficiently without the need of reformulation.
Awards & Recognitions
MassChallenge Switzerland & Healthcare Accelerator Finalist - 2022 (On-going)
MedTech Innovator APAC Grand Prize Winner - 2021
Cambridge Consultants Product Development Award - 2021
Deloitte Raising Star Award - 2017
45th International Exhibition of Invention Geneva - 2017
Prize of the State of Geneva; Prize of ULBS Romania
IET Innovation Award Winner (Healthcare) - 2016
Google We Solve for X Moonshot Project
Kairos' Society K50 Global Top 50 Startups - 2015
Rice Business Plan Competition Top 6 Semi-finalist - 2015
TiE International Business Plan Competition - 2015
Winner (Hong Kong & Asia); Asia Rising Star Award
HKUST 4th Annual One Million Dollar Entrepreneurship Competition 2nd Prize Winner
Media & Press